Potentially procholinergic effects of medications commonly used in older adults

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 1, 2011, Pages 80-87

  Rockwood, Kenneth ^a   Walsh, Ryan ^b   Martin, Earl ^c   Darvesh, Sultan ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CARLETON UNIVERSITY   (Canada)

^c MOUNT SAINT VINCENT UNIVERSITY   (Canada)

Author keywords

acetylcholinesterase; aged; butyrylcholinesterase; citalopram; donepezil; Ellman method; galantamine; indapamide; perindopril; procholinergic; quetiapine; ranitidine; risperidone; trazodone

Indexed keywords

ACETYLCHOLINESTERASE; AMITRIPTYLINE; ATENOLOL; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DIGOXIN; DIMENHYDRINATE; ENALAPRIL; FENOPROFEN; FLUOXETINE; FLURBIPROFEN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDAPAMIDE; INDOMETACIN; METOPROLOL; OMEPRAZOLE; OXYBUTYNIN; PARACETAMOL; PAROXETINE; PERINDOPRIL; PREDNISONE; QUETIAPINE; RANITIDINE; RISPERIDONE; TRAZODONE; UNINDEXED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHOLINESTERASE INHIBITION; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; GERIATRIC PATIENT; IC 50; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ACETYLCHOLINESTERASE; AGE FACTORS; AGED; ALZHEIMER DISEASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; HUMANS;

EID: 79953705387     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.02.003     Document Type: Article

References (16)

1. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc. 1991;39:1093-1099.
2. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007;62:722-727. (Pubitemid 350143602)
3. Landi FM, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81:235-241. (Pubitemid 46174821)
4. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62:11-14. (Pubitemid 32937572)
5. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422-429. (Pubitemid 351272629)
6. Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:458-461. (Pubitemid 36807643)
7. Birks J. Cholinesterase ihibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;1:CD005593.
8. Darvesh S, Walsh R, Kumar R, et al. Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord. 2003;17:117-126. (Pubitemid 36736847)
9. Darvesh S, Martin E, Walsh R, Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004;37:42-49. (Pubitemid 37522124)
10. Ellman GL, Courtney KD, AndresVJr, Featherstone RM.A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
11. Fylstra D, Lasdon L, Watson J, Waren A. Design and use of the Microsoft Excel Solver. Interfaces. 1998;28:29-55.
12. Nenov IP, Fyltstra DH. Interval methods for accelerated global search in the Microsoft Excel Solver. Reliab Comput. 2003;9:143-159.
13. Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci. 2003;4:131-138. (Pubitemid 37271383)
14. Smith GS, Kramer E, Ma Y, et al. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. Brain. 2009;132:392-401.
15. Farlow MR, Salloway S, Tariot PN, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. Clin Ther. 2010;32:1234-1251.
16. Becker RE, Giacobini E. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: Clinical, pharmacological, and therapeutic aspects. Drug Development Res. 1988;12:163-195.